OA05.03 Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFRTKI and Platinum-Based Chemotherapy: HERTHENA-Lung01Helena A. Yu, Pasi A. Jänne, Benjamin Besse et al.|Journal of Thoracic Oncology|2023Cited by 1